Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
Goldstein
Mark R
MR
Mascitelli
Luca
L
Pezzetta
Francesca
F
D000367:Age Factors; D000368:Aged; D000069059:Atorvastatin; D015984:Causality; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004305:Dose-Response Relationship, Drug; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006973:Hypertension / Q000150:complications; D007049:Iatrogenic Disease / Q000517:prevention & control; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D011758:Pyrroles / Q000008:administration & dosage* / Q000009:adverse effects*; D012737:Sex Factors
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin